Lubrizol LifeSciences has added cGMP sterile powder filling and capsule filling at their Particle Sciences facility.  

“In response to client needs, we are expanding our cGMP powder handling capabilities,” said Robert Lee, vice president of pharmaceutical development services, Particle Sciences. “There has been an uptick in our partners’ need for sterile powder filling, both in vials and proprietary devices. To meet this need, we have acquired and qualified the necessary equipment. Powder fills from 50 mg to 75 g, with an accuracy of up to +/- 1% of fill volume, are possible, including those for highly potent compounds,”

As a developer of particulates, utilizing both standard and proprietary approaches, the Particle Sciences’ facility is supported by full development and analytic services. As previously announced, commercial production at that location will come online in 2017.

“Also included in this latest capability expansion is capsule filling,” said Mr. Lee. “With a clinical supply capability of 3,000 capsules—sizes 0-4—per hour, we are positioned to assist our clients in utilizing our bioavailability-enhancing platforms in oral dosage forms.”